Immune cell therapies and stem cell therapies are receiving increasing amounts of attention for their potential use as treatments for pathologies that include cancer, immune disorders, and cardiovascular disease. Perhaps the most attention has focused on cancer T cell therapies where the patient's own cells are used in the treatment. A common workflow includes enrichment of the cells of interest followed by genetic modifications and ex vivo expansion of the cells. The cells, now reprogrammed for enhanced anti-tumor activity, are then re-introduced into the patient. Some cell types used for immune cell therapy include tumor-infiltrating lymphocytes (TILs), transgenic TCR T cells, and chimeric antigen receptor (CAR) T cells. R&D Systems offers reagents and kits for every step of the cell therapy workflow.
Consistent proteins, secure supply, and scalability to meet you needs for cell therapy manufacturing.
Utilize our MagCellect™ Cell Selection Kits and Reagents to quickly and easily isolate cell populations by negative selection.
Cytokine cocktails and optimized protocols to expand and differentiate Th1, Th2, Th17, Dendritic Cells, Macrophages, NK cells, B Cells, Tregs and more.
We offer growth factors, small molecules, media, and complete kits to verify stem cell potency and drive differentiation for regenerative medicine research.
View our wide range of flow antibodies to identify memory T cell subsets for more effective T cell therapies.
Use our immunoassays and kits to measure cytokine secretion, proliferation, and cytotoxicity to ensure T cells are functioning as expected.
View hallmarks of T cell exhaustion and find the proteins, antibodies, ELISAs, and antibody arrays you need to monitor them.
Quickly identify similarities and differences between CAR T cells and conventional T cells with Proteome Profiler™ Antibody Arrays.
Offering RUO to GMP conversion of proteins, custom Luminex® panels, chemistry services, and more.